<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Seasonal influenza and pregnancy
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Seasonal influenza and pregnancy
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Seasonal influenza and pregnancy
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Denise J Jamieson, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sonja A Rasmussen, MD, MS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vincenzo Berghella, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Martin S Hirsch, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alana Chakrabarti, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elinor L Baron, MD, DTMH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 08, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H5795624">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Influenza is an acute respiratory illness caused by influenza A or B viruses that occurs in outbreaks and epidemics worldwide, mainly during the winter season [
         <a href="#rid1">
          1-4
         </a>
         ]. Influenza-associated morbidity and mortality are higher among pregnant and recently postpartum patients (within two weeks after delivery or pregnancy loss) than the general population [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         This topic will discuss issues specific to seasonal influenza in pregnant and postpartum patients. Information on seasonal influenza in nonpregnant patients is discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7006.html" rel="external">
          "Influenza: Epidemiology and pathogenesis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7004.html" rel="external">
          "Seasonal influenza in adults: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6998.html" rel="external">
          "Seasonal influenza in nonpregnant adults: Treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7017.html" rel="external">
          "Seasonal influenza in adults: Role of antiviral prophylaxis for prevention"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7008.html" rel="external">
          "Antiviral drugs for influenza: Pharmacology and resistance"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">
          "Seasonal influenza vaccination in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1511340378">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical manifestations of influenza in pregnant and postpartum patients are similar to those in the general population, but the symptoms are typically more severe. Influenza characteristically begins with the abrupt onset of fever, nonproductive cough, and myalgia. Fever usually ranges from 37.8 to 40.0°C (100 to 104°F). Other nonspecific symptoms include malaise, sore throat, nausea, nasal congestion, and headache. (See
         <a class="medical medical_review" href="/z/d/html/7004.html" rel="external">
          "Seasonal influenza in adults: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         These clinical features overlap substantially with those of other respiratory viral illnesses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; the virus that causes coronavirus disease 2019 [COVID-19]), and there is no way to accurately distinguish between them in the absence of diagnostic testing. In addition, coinfection with influenza and SARS-CoV-2 can occur, albeit rarely. (See
         <a class="medical medical_review" href="/z/d/html/7004.html" rel="external">
          "Seasonal influenza in adults: Clinical manifestations and diagnosis", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4289601430">
         <span class="h1">
          EFFECTS ON PREGNANCY
         </span>
        </p>
        <p class="headingAnchor" id="H1511340317">
         <span class="h2">
          Maternal effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data from influenza pandemics over the last century (including the pandemics of 1918 to 1919, 1957 to 1958, and 2009 to 2010) have shown that pregnant patients are more likely to have a more severe clinical course, be hospitalized and admitted to an intensive care unit, and to die compared with the general population [
         <a href="#rid3">
          3,5-13
         </a>
         ]. Pregnant patients with comorbidities (eg, chronic cardiac or pulmonary disease, diabetes mellitus, chronic renal disease, malignancy, immunosuppression) are at an even greater risk of complications from influenza than their nonpregnant counterparts [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         During the 2009 H1N1 pandemic, pregnant individuals accounted for 5 percent of all influenza deaths even though they comprised only 1 percent of the United States population [
         <a href="#rid14">
          14,15
         </a>
         ]. In addition, 12 percent of pregnancy-related deaths during the 2009 to 2010 pandemic season were attributed to confirmed or suspected H1N1 influenza A virus infection [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         In a subsequent retrospective study including more than 2600 pregnant patients hospitalized with influenza between 2010 and 2019 (most of whom were in their third trimester and only one-third of all patients were vaccinated against influenza), severe maternal illness requiring intensive care occurred in 5 percent [
         <a href="#rid17">
          17
         </a>
         ]. There were eight maternal deaths (half of which occurred in the unvaccinated group). Influenza A H1N1, when compared with other influenza subtypes, was associated with more severe maternal outcomes.
        </p>
        <p class="headingAnchor" id="H5795638">
         <span class="h2">
          Fetal effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transplacental transmission of influenza virus appears to be rare [
         <a href="#rid18">
          18
         </a>
         ]. However, maternal influenza during pregnancy may have adverse effects on the fetus even in the absence of transplacental transmission.
        </p>
        <p>
         Maternal influenza virus infection may be associated with fetal congenital anomalies. In a systematic review and meta-analysis of observational studies, influenza or influenza-like illness in the first trimester was associated with an increased risk of congenital abnormalities (adjusted odds ratio [OR] for any anomaly 2, 95% CI 1.62-2.48), including cleft lip (OR 3.2), neural tube defects (OR 3.3), hydrocephaly (OR 5.7), and congenital heart defects (OR 1.6) [
         <a href="#rid19">
          19
         </a>
         ]. Hyperthermia, a common clinical manifestation of influenza, is also a risk factor for certain congenital anomalies; this risk appears to be attenuated by use of antipyretics [
         <a href="#rid20">
          20
         </a>
         ]. (See
         <a class="local">
          'Symptom management'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/460.html" rel="external">
          "Neural tube defects: Overview of prenatal screening, evaluation, and pregnancy management", section on 'Fever/hyperthermia'
         </a>
         .)
        </p>
        <p>
         Maternal influenza during pregnancy may also be associated with an increased risk for pregnancy loss, preterm birth, low birth weight, birth of a small-for-gestational-age (SGA) infant, and fetal death [
         <a href="#rid5">
          5,11,21-28
         </a>
         ]. In the 2009 H1N1 pandemic, only severely ill pregnant patients (ie, those admitted to an intensive care unit) had a substantially increased risk of poor infant outcomes (eg, preterm labor, low birth weight) [
         <a href="#rid29">
          29
         </a>
         ]. In the retrospective study including pregnant patients hospitalized with influenza and mentioned above (see
         <a class="local">
          'Maternal effects'
         </a>
         above), fetal loss occurred in 3 percent of patients no longer pregnant at discharge; the majority of these losses occurred in the first and second trimesters [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H431017289">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of influenza should be suspected in patients with abrupt onset of fever, cough, and myalgia when influenza virus activity is present in the community (in the northern hemisphere, typically September to April; in the southern hemisphere, typically April to September). Other symptoms, such as malaise, sore throat, nausea, nasal congestion, and headache, are common in the setting of influenza as well.
        </p>
        <p>
         A positive test for influenza virus confirms the diagnosis. However, a negative test for influenza virus cannot rule out infection, especially if the test does not have adequate sensitivity or if the specimen was collected &gt;4 days after illness onset. (See
         <a class="medical medical_review" href="/z/d/html/7004.html" rel="external">
          "Seasonal influenza in adults: Clinical manifestations and diagnosis", section on 'Diagnosis of influenza'
         </a>
         .)
        </p>
        <p>
         Pregnant and recently postpartum patients (within two weeks after delivery) with suspected influenza should also undergo testing for SARS-CoV-2. (See
         <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">
          "COVID-19: Diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1876578584">
         <span class="h1">
          MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H3365306180">
         <span class="h2">
          Infection control measures
         </span>
         <span class="headingEndMark">
          —
         </span>
         General issues related to infection control measures for prevention of seasonal influenza (eg, hand and respiratory hygiene, droplet precautions) are the same as for nonpregnant patients and are presented in the table  (
         <a class="graphic graphic_table graphicRef50001" href="/z/d/graphic/50001.html" rel="external">
          table 1
         </a>
         ) and discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6999.html" rel="external">
          "Infection control measures for prevention of seasonal influenza"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1854377860">
         <span class="h2">
          Pregnant and recently postpartum patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pregnant and recently postpartum patients (within two weeks after delivery) at moderate to increased risk for complications include those with [
         <a href="#rid4">
          4
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inability to retain fluids
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Signs of dehydration
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Shortness of breath
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chest pain or pressure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Altered mental status
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Comorbidities (eg, human immunodeficiency virus [HIV], asthma)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obstetric complications (eg, preterm labor)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Worsening symptoms after previous improvement
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inability to care for self
        </p>
        <p>
        </p>
        <p>
         These patients should be referred immediately to an emergency department or equivalent setting for evaluation, possible admission, and treatment. Hospitalization is warranted for patients with significant dehydration and for severely ill patients, especially those with respiratory distress, hypoxemia, impaired cardiopulmonary function, or altered mental status. For patients at risk for complications but without these findings, admission for observation may be warranted.
        </p>
        <p>
         Patients without an increased risk of complication may be managed via phone or other remote communication unless other issues warrant an office visit. In such cases, plans should be made for follow-up by phone in 24 to 48 hours to assess change in status.
        </p>
        <p class="headingAnchor" id="H2259167923">
         <span class="h3">
          Antiviral treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Decisions regarding antiviral treatment for influenza should be based on clinical circumstances and current information regarding circulating influenza virus in the community; antiviral treatment should
         <strong>
          not
         </strong>
         be withheld while awaiting results of diagnostic testing (including testing for SARS-CoV-2 [ie, COVID-19]). (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H247316338">
         <span class="h4">
          Timing
         </span>
         <span class="headingEndMark">
          —
         </span>
         For pregnant and postpartum patients (within two weeks of delivery) with suspected or confirmed influenza, we recommend antiviral treatment as early as possible, regardless of vaccination status. While the benefits of antiviral therapy are greatest when initiated within the first 48 hours following symptom onset, antiviral treatment is also warranted for patients who present &gt;48 hours after symptom onset, particularly if their clinical condition has not started to improve.
        </p>
        <p>
         Delay of treatment is associated with worse outcomes. In one retrospective study including 788 pregnant patients with 2009 H1N1 influenza, those who received treatment &gt;4 days compared with ≤2 days after symptom onset were more likely to be admitted to an intensive care unit (56.9 versus 9.4 percent; relative risk [RR] 6; 95% CI 3.5-10.6) [
         <a href="#rid14">
          14
         </a>
         ]. Similarly, in a subsequent retrospective study including 959 pregnant patients with 2009 H1N1 influenza, those who received antiviral treatment ≥2 days compared with &lt;2 days after diagnosis were more likely to be hospitalized (OR 3.4, 95% CI 1.6-7.6) [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3185006388">
         <span class="h4">
          Antiviral agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         Information regarding antiviral selection, dosing, and duration for pregnant patients is outlined below. Additional information related to antiviral agents is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6998.html" rel="external">
          "Seasonal influenza in nonpregnant adults: Treatment", section on 'Antiviral agents'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Selection
         </strong>
         –
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          Oseltamivir
         </a>
         is the preferred antiviral agent for treatment of pregnant patients with influenza as it is the agent for which there is greatest clinical experience [
         <a href="#rid31">
          31
         </a>
         ]. Other neuraminidase inhibitors (ie,
         <a class="drug drug_general" data-topicid="10323" href="/z/d/drug information/10323.html" rel="external">
          zanamivir
         </a>
         ,
         <a class="drug drug_general" data-topicid="9527" href="/z/d/drug information/9527.html" rel="external">
          peramivir
         </a>
         ) are acceptable alternative agents for treatment of pregnant patients; however, zanamivir is relatively contraindicated in patients with asthma or chronic obstructive pulmonary disease and peramivir is only available intravenously.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <a class="drug drug_general" data-topicid="119458" href="/z/d/drug information/119458.html" rel="external">
          Baloxavir
         </a>
         is
         <strong>
          not
         </strong>
         generally recommended for pregnant or postpartum patients given lack of safety and efficacy data. If there is a compelling reason to use baloxavir during pregnancy, the risks and benefits must be weighted carefully [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dosing
         </strong>
         – Dosing of antiviral agents for treatment of influenza during pregnancy is the same as in nonpregnant adults [
         <a href="#rid4">
          4,31
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Preferred agent:
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          Oseltamivir
         </a>
         75 mg twice daily for five days
         <strong>
         </strong>
         (preferred)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Alternative agents:
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="10323" href="/z/d/drug information/10323.html" rel="external">
          Zanamivir
         </a>
         10 mg (two 5 mg inhalations) twice daily for five days
         <strong>
          or
         </strong>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <a class="drug drug_general" data-topicid="9527" href="/z/d/drug information/9527.html" rel="external">
          Peramivir
         </a>
         600 mg intravenously (infused over a minimum of 15 minutes) administered as a single dose
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         There is no role for increasing the
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          oseltamivir
         </a>
         dose, given the lack of greater benefit at higher doses [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Duration
         </strong>
         – In general, we administer
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          oseltamivir
         </a>
         for five days.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A longer duration of treatment (up to 10 days) may be warranted for immunocompromised or severely ill patients, particularly in those who continue to have detectable influenza virus ribonucleic acid (RNA) from a respiratory specimen after five days of antiviral treatment. (See
         <a class="medical medical_review" href="/z/d/html/6998.html" rel="external">
          "Seasonal influenza in nonpregnant adults: Treatment", section on 'Antiviral duration'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Safety data
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pregnancy
         </strong>
         – Data on the safety of
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          oseltamivir
         </a>
         ,
         <a class="drug drug_general" data-topicid="10323" href="/z/d/drug information/10323.html" rel="external">
          zanamivir
         </a>
         , and
         <a class="drug drug_general" data-topicid="9527" href="/z/d/drug information/9527.html" rel="external">
          peramivir
         </a>
         during pregnancy are limited, especially during the first trimester; however, the benefits of early treatment appear to outweigh the potential risks [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         In a meta-analysis including nine cohort studies evaluating neonatal outcomes after exposure to neuraminidase inhibitors during pregnancy, those exposed to neuraminidase inhibitors compared with unexposed infants had similar rates of preterm birth, congenital malformations, and low Apgar scores [
         <a href="#rid33">
          33
         </a>
         ]. In addition, exposure to neuraminidase inhibitors was associated with reduced rates of low birth weight (odds ratio [OR] 0.79, 95% CI 0.68-0.92) and small-for-gestational-age (SGA) infants (OR 0.78, 95% CI 0.69-0.88). In one retrospective study not included in this meta-analysis, rates of intestinal malrotation were increased among infants exposed to
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          oseltamivir
         </a>
         (3 out of 121 infants; OR 10.7, 95% CI 1.8-45.2) [
         <a href="#rid34">
          34
         </a>
         ]. However, given this association is based only on three infants, and the OR had wide confidence intervals, the authors noted that this finding might be due to chance. This association has not been described previously and requires further study.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Lactation
         </strong>
         – Use of
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          oseltamivir
         </a>
         by breastfeeding mothers appears to pose no harm to their infants [
         <a href="#rid35">
          35,36
         </a>
         ]. The drug and its active metabolite are poorly excreted into breast milk [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         We are not aware of any studies on the safety of
         <a class="drug drug_general" data-topicid="10323" href="/z/d/drug information/10323.html" rel="external">
          zanamivir
         </a>
         or
         <a class="drug drug_general" data-topicid="9527" href="/z/d/drug information/9527.html" rel="external">
          peramivir
         </a>
         during breastfeeding.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1560204581">
         <span class="h3">
          Symptom management
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          Acetaminophen
         </a>
         is used to treat fever [
         <a href="#rid38">
          38
         </a>
         ], since hyperthermia during the first trimester has been associated with neural tube defects and possibly other congenital anomalies (see
         <a class="local">
          'Fetal effects'
         </a>
         above). In addition, fever during labor may be a risk factor for neonatal seizures, encephalopathy, cerebral palsy, and neonatal death [
         <a href="#rid20">
          20,39,40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/112420.html" rel="external">
          "Prenatal care: Patient education, health promotion, and safety of commonly used drugs", section on 'Acetaminophen'
         </a>
         .)
        </p>
        <p>
         Other antipyretics (eg,
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         , nonsteroidal antiinflammatory drugs [NSAIDs]) should be avoided as they may be associated with adverse pregnancy and infant outcomes (eg, oligohydramnios, premature closure of the ductus arteriosus); low-dose aspirin given for obstetric indications may be continued during pregnancy. (See
         <a class="medical medical_review" href="/z/d/html/112420.html" rel="external">
          "Prenatal care: Patient education, health promotion, and safety of commonly used drugs", section on 'NSAIDs'
         </a>
         .)
        </p>
        <p>
         Symptomatic therapy (for cough, rhinorrhea, sore throat, headache, and myalgia) is similar to that for pregnant patients with the common cold and is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/4793.html" rel="external">
          "Approach to the pregnant patient with a respiratory infection", section on 'The common cold'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3116468721">
         <span class="h3">
          Concomitant infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Empiric treatment for concomitant bacterial pneumonia (in addition to antiviral treatment for influenza) is warranted for selected patients with influenza including patients who [
         <a href="#rid3">
          3
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Present with respiratory failure and/or hemodynamic instability, or
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fail to improve after three to five days of antiviral therapy and supportive care, or
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Develop fever after defervescence
        </p>
        <p>
        </p>
        <p>
         Antibiotic selection should be guided by Gram stain and culture of sputum, if available. If the etiology of the pneumonia is uncertain, empiric antibiotics effective against the organisms commonly implicated in secondary bacterial pneumonia among patients with influenza (
         <em>
          Streptococcus pneumoniae
         </em>
         ,
         <em>
          Streptococcus pyogenes,
         </em>
         and
         <em>
          Staphylococcus aureus
         </em>
         )
         <em>
         </em>
         should be used.
        </p>
        <p>
         Agents with activity against
         <em>
          S. pneumoniae
         </em>
         and
         <em>
          S. pyogenes
         </em>
         include third-generation cephalosporins (such as
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         ). Empiric treatment for methicillin-resistant
         <em>
          S. aureus
         </em>
         infection with
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         should be initiated in patients with severe or necrotizing pneumonia [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7027.html" rel="external">
          "Treatment of community-acquired pneumonia in adults who require hospitalization"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H587739506">
         <span class="h3">
          Role of fetal monitoring
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are no published guidelines for fetal monitoring during or after maternal influenza virus infection. The type and frequency of fetal surveillance is determined on a case-by-case basis and guided by the patient's overall condition and the health care provider's judgment. Decisions about timing of delivery should be based on standard obstetric indications. (See
         <a class="medical medical_review" href="/z/d/html/457.html" rel="external">
          "Overview of antepartum fetal assessment", section on 'Indications for fetal assessment'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3859908298">
         <span class="h2">
          Newborns
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Routine care
         </strong>
         – Asymptomatic newborns (born in the hospital with infection control precautions) should be considered exposed, not infected; these newborns may receive care in the nursery using standard precautions and should be observed for signs of infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Issues related to clinical manifestations, diagnosis, and management of children with influenza are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">
          "Seasonal influenza in children: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5985.html" rel="external">
          "Seasonal influenza in children: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Considerations for temporary separation
         </strong>
         – Given the risk of influenza complications in newborns, the United States Centers for Disease Control (CDC) recommends considering temporary separation of a mother with suspected or confirmed influenza from the newborn (with feedings of expressed breast milk or formula provided by a healthy caregiver). The duration of separation is individualized; there are no data on which to formulate evidence-based recommendations. CDC guidelines developed during the 2009 H1N1 pandemic recommended separation until
         <strong>
          all
         </strong>
         of the following criteria were met [
         <a href="#rid41">
          41
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The mother has received antiviral medication for 48 hours.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The mother has been afebrile without antipyretics for &gt;24 hours.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The mother can control coughing and respiratory secretions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If temporary separation is not feasible, physical distancing (eg keeping the healthy newborn &gt;6 feet away from the ill mother as feasible) is advisable.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role of antiviral prophylaxis
         </strong>
         – For asymptomatic healthy-term newborns, routine use of
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          oseltamivir
         </a>
         for prophylaxis is
         <strong>
          not
         </strong>
         recommended given limited safety and efficacy data in this age group.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Issues related to influenza prophylaxis in children are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/132409.html" rel="external">
          "Seasonal influenza in children: Prevention with antiviral drugs"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1061207898">
         <span class="h2">
          Household contacts and infant caregivers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Issues related to antiviral prophylaxis for household members and infant caretakers who have close contact with an individual with influenza are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7017.html" rel="external">
          "Seasonal influenza in adults: Role of antiviral prophylaxis for prevention", section on 'Postexposure antiviral prophylaxis'
         </a>
         .)
        </p>
        <p>
         All eligible household members (including children ≥6 months of age) and infant caretakers should be vaccinated against influenza virus. (See
         <a class="local">
          'Prevention'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">
          "Seasonal influenza vaccination in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5960.html" rel="external">
          "Seasonal influenza in children: Prevention with vaccines"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5795652">
         <span class="h1">
          PREVENTION
         </span>
        </p>
        <p class="headingAnchor" id="H5795661">
         <span class="h2">
          Vaccination
         </span>
         <span class="headingEndMark">
          —
         </span>
         We recommend influenza virus vaccination for all patients who are pregnant or might be pregnant or postpartum (within two weeks after delivery) during influenza season; this is consistent with the recommendations from the United States Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) and American College of Obstetricians and Gynecologists (ACOG) [
         <a href="#rid1">
          1,42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3169111857">
         <span class="h3">
          Administration
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Timing
         </strong>
         – For pregnant patients in the first or second trimester during the summer months, influenza vaccination should be offered before community onset of influenza virus activity (during September or October in the northern hemisphere and during March or April in the southern hemisphere) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For pregnant patients in the third trimester during the summer months, earlier vaccination (July/August in the northern hemisphere, or January/February in the southern hemisphere) may be considered; this approach may reduce risk for influenza illness among their infants during the first months after birth, when they are too young to receive the influenza vaccine [
         <a href="#rid1">
          1,27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vaccine selection
         </strong>
         – Pregnant patients may be immunized with any licensed
         <a class="drug drug_general" data-topicid="9055" href="/z/d/drug information/9055.html" rel="external">
          inactivated influenza vaccine
         </a>
         (IIV) or recombinant influenza vaccine [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">
          "Seasonal influenza vaccination in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Pregnant patients should
         <strong>
          not
         </strong>
         be immunized with a live-attenuated influenza vaccine (LAIV) due to concerns about the safety of a live vaccine administered during pregnancy [
         <a href="#rid1">
          1
         </a>
         ]. It is not necessary for pregnant patients to avoid contact with others who have recently received LAIV. Postpartum patients may receive a live virus vaccine. (See
         <a class="medical medical_review" href="/z/d/html/442.html" rel="external">
          "Immunizations during pregnancy", section on 'Live vaccines'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Issues related to influenza vaccination for individuals with egg allergy are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2389.html" rel="external">
          "Influenza vaccination in persons with egg allergy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increasing uptake
         </strong>
         – Vaccine uptake remains suboptimal [
         <a href="#rid43">
          43
         </a>
         ]. In one survey of pregnant individuals in the United States from 2022 to 2023, only 47 percent reported receiving the influenza vaccine [
         <a href="#rid44">
          44
         </a>
         ]. Vaccination rates in pregnant patients in other countries are also suboptimal [
         <a href="#rid45">
          45
         </a>
         ]. The most commonly reported reason for not receiving influenza vaccination in pregnancy is the belief that the vaccine is not effective [
         <a href="#rid46">
          46
         </a>
         ]. Rates of influenza vaccination during pregnancy are highest when the provider recommends and offers the vaccine [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1511341276">
         <span class="h3">
          Efficacy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Influenza vaccination plays a key role in reducing the risk of maternal influenza illness and hospitalization, improving pregnancy outcomes, and protecting the infant for several months after birth.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reducing maternal influenza illness
         </strong>
         <strong>
          and hospitalization
         </strong>
         – Influenza vaccination plays a key role in reducing the risk of maternal influenza illness. Pregnant patients achieve seroprotection at rates similar to nonpregnant patients [
         <a href="#rid26">
          26,48
         </a>
         ], although there may be some differences in the antibody response of pregnant patients to influenza vaccine compared with nonpregnant patients [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a systematic review and meta-analysis of cohort studies of vaccination for preventing influenza in healthy adults, H1N1 vaccines reduced the risk of influenza-like illness in pregnant patients by 89 percent (95% CI 79-94) and the seasonal vaccine reduced the risk of influenza-like illness in pregnant patients by 24 percent (95% CI 11-35) [
         <a href="#rid50">
          50
         </a>
         ]. Reductions in influenza-like illness have also been reported in randomized trials and large case-control study not reported in this systematic review [
         <a href="#rid51">
          51-53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Influenza vaccination also reduces the risk of influenza-related hospitalizations. In a study including pregnant patients from hospitals in Australia, Canada, Israel, and the United States between 2010 and 2016, the influenza vaccine was 40 percent effective (adjusted vaccine effectiveness 40 percent, 95% CI 12-59 percent) in preventing laboratory-confirmed influenza-associated hospitalization [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Improving pregnancy outcome
         </strong>
         – Influenza vaccination improves pregnancy outcomes. In a systematic review and meta-analysis of observational studies on the effect of maternal influenza immunization on stillbirth and pregnancy loss, influenza vaccination was associated with a reduction in risk of stillbirth (relative risk [RR] 0.73, 95% CI 0.55-0.96) but not pregnancy loss [
         <a href="#rid55">
          55
         </a>
         ]. Others have reported influenza vaccination is associated with a reduced risk for small-for-gestational-age (SGA) infants and preterm delivery [
         <a href="#rid52">
          52,56-60
         </a>
         ] and an increase in birth weight [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infant protection
         </strong>
         – In addition to protecting the pregnant patient, influenza vaccination during pregnancy protects the infant for several months after birth [
         <a href="#rid52">
          52,61-69
         </a>
         ]. In the systematic review and meta-analysis of cohort studies discussed above, newborns of vaccinated patients had a 41 percent (95% CI 6-63) reduction in laboratory-confirmed influenza [
         <a href="#rid50">
          50
         </a>
         ]. Similarly, in a random effects meta-analysis of two randomized trials including 5742 participants in South Africa and Nepal, maternal influenza vaccination was associated with a 34 percent overall reduction of laboratory confirmed influenza among infants (95% CI 15-50 percent) [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Antenatal maternal immunization induces substantial levels of anti-influenza-specific serum immunoglobulin G (IgG), which are actively transferred across the placenta to the fetus [
         <a href="#rid71">
          71
         </a>
         ], and anti-influenza-specific IgA in breast milk, which is transferred to the infant during lactation [
         <a href="#rid72">
          72
         </a>
         ]. Thus, antenatal maternal vaccination is an effective strategy for reducing influenza-related morbidity and mortality among infants, who are at increased risk for severe influenza illness and not eligible for vaccination until six months of age because they fail to mount an adequate immune response [
         <a href="#rid73">
          73,74
         </a>
         ]. Maternal vaccine may also reduce hospitalizations for all-cause acute lower respiratory tract infection before three months of age [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, passive protection afforded by maternal influenza vaccination declines significantly before the infant is eligible for influenza virus vaccination. In a randomized trial of 1026 infants of patients who received trivalent IIV during pregnancy and 1023 infants of patients who received a placebo, the vaccine's efficacy against polymerase chain reaction (PCR)-confirmed influenza illness was approximately 86 percent in infants ≤8 weeks of age and 25 to 30 percent in infants 8 to 24 weeks of age [
         <a href="#rid66">
          66
         </a>
         ]. The percentage of infants with hemagglutination inhibition antibody titers ≥1:40 to the influenza vaccine strains targeted by the vaccine was ≥56 percent in the first week and fell to &lt;10 percent at 24 weeks of age. Others have observed similar decreases in vaccine efficacy over time [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         It is possible that maternal immunization in the third trimester would improve passive protection for the newborn [
         <a href="#rid76">
          76
         </a>
         ], as with Tdap; however, delaying maternal immunization places the mother at risk for influenza and its sequelae (maternal and fetal) and is not recommended.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3229565210">
         <span class="h3">
          Safety
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although pregnant patients often have concerns about the safety of vaccines for their fetuses, multiple studies have
         <strong>
          not
         </strong>
         shown an increased risk of complications associated with administration of IIVs to pregnant patients compared with the general population [
         <a href="#rid26">
          26,50,52,77-95
         </a>
         ]. Similarly, no significant adverse pregnancy or fetal outcomes have been observed among pregnant patients who have received influenza vaccination. In a systematic review and meta-analysis including seven studies, patients who received influenza vaccine compared with no vaccination had a lower likelihood of stillbirth (RR 0.73, 95% CI 0.55-0.96) but a similar rate of pregnancy loss [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Although influenza vaccines that contain adjuvants (substances that boost the immune response and potentially provide longer-lasting and broader protection against antigenically-drifted viruses) are only approved in the United States for use in individuals ≥65 years of age, experience from Europe provides limited but reassuring data on the safety of adjuvant-containing influenza vaccines administered to pregnant patients [
         <a href="#rid96">
          96-98
         </a>
         ].
        </p>
        <p>
         There is no evidence that vaccines that contain thimerosal are harmful to the children of patients who received thimerosal-containing vaccines during pregnancy. However, thimerosal-free formulations of the seasonal influenza vaccine are available. (See
         <a class="medical medical_review" href="/z/d/html/2846.html" rel="external">
          "Standard childhood vaccines: Caregiver hesitancy or refusal", section on 'Influenza vaccine misinformation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5795668">
         <span class="h2">
          Role of antiviral prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antiviral drugs may be useful adjunctive tools for prevention of influenza in certain circumstances but should not be used as a substitute for vaccination.
        </p>
        <p>
         The role of pre-exposure and postexposure prophylaxis for prevention of influenza is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7017.html" rel="external">
          "Seasonal influenza in adults: Role of antiviral prophylaxis for prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3909170866">
         <span class="h1">
          SOCIETY ALGORITHM LINK
         </span>
         <span class="headingEndMark">
          —
         </span>
         The American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine have jointly published an
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.acog.org%2Fen%2FClinical%2FClinical+Guidance%2FCommittee+Opinion%2FArticles%2F2018%2F10%2FAssessment+and+Treatment+of+Pregnant+Women+With+Suspected+or+Confirmed+Influenza&amp;token=yG0F0NplKPjLKPhsBHUEED6wIxqrTqIXFv3hh7OPQVszlNH%2B7c1zTVTck7%2FD0C5PJKPWZSGz9p8L5Gic5h7SHsWoV5nOmlYKhNkAA86JArRX7znlM%2BW6sOpG6oSbR8i60WQoZVJPp0aRY2Exmr5TGKLO1FV4UfqR0%2BfDHwJ5KbOFVy3Q8BCquSssDk97zBjq&amp;TOPIC_ID=15870" target="_blank">
          algorithm
         </a>
         for assessment and treatment of pregnant patients with influenza-like illness.
        </p>
        <p class="headingAnchor" id="H3366692580">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110427.html" rel="external">
          "Society guideline links: Immunizations in adults"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/110758.html" rel="external">
          "Society guideline links: Seasonal influenza vaccination"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/121862.html" rel="external">
          "Society guideline links: Respiratory disease in pregnancy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5795733">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General principles
         </strong>
         – Pregnant patients with seasonal influenza are more likely to be hospitalized and admitted to an intensive care unit and have a higher mortality compared with the general population. Maternal influenza also increases the risk of adverse fetal outcomes (eg, congenital anomalies, preterm birth, fetal death). (See
         <a class="local">
          'Effects on pregnancy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Clinical manifestations of influenza in pregnant and postpartum patients are similar to those in the general population and include an abrupt onset of fever, nonproductive cough, and myalgia. Other nonspecific symptoms include malaise, sore throat, nausea, nasal congestion, and headache. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of uncomplicated influenza should be suspected in patients with abrupt onset of fever, cough, and myalgia when influenza virus is circulating (in the northern hemisphere, typically September to April; in the southern hemisphere, typically April to September). A positive test for influenza virus confirms the diagnosis. However, a negative test for influenza virus cannot rule out infection, especially if the test does not have adequate sensitivity or if the specimen was collected &gt;4 days after illness onset. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Infection control
         </strong>
         – General issues related to infection control measures for prevention of seasonal influenza (eg, hand and respiratory hygiene, droplet precautions) are the same as for nonpregnant patients and presented in the table  (
         <a class="graphic graphic_table graphicRef50001" href="/z/d/graphic/50001.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Infection control measures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pregnancy and recently postpartum patients
         </strong>
         – For pregnant and postpartum patients (within two weeks of delivery or pregnancy loss) with suspected or confirmed influenza, we recommend influenza antiviral treatment as early as possible, regardless of vaccination status (
         <a class="grade" href="https:///uptodate/show/grade_3" rel="external">
          Grade 1C
         </a>
         ). Treatment should not be withheld while awaiting results of diagnostic testing or in situations in which testing is not performed. (See
         <a class="local">
          'Antiviral treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Antiviral selection
         </strong>
         – We suggest treatment with
         <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">
          oseltamivir
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Alternative agents include
         <a class="drug drug_general" data-topicid="9527" href="/z/d/drug information/9527.html" rel="external">
          peramivir
         </a>
         or
         <a class="drug drug_general" data-topicid="10323" href="/z/d/drug information/10323.html" rel="external">
          zanamivir
         </a>
         ; dosing is summarized above.
         <a class="drug drug_general" data-topicid="119458" href="/z/d/drug information/119458.html" rel="external">
          Baloxavir
         </a>
         , however, is
         <strong>
          not
         </strong>
         generally used for pregnant or postpartum patients given lack of safety and efficacy data. (See
         <a class="local">
          'Antiviral agents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Symptom management
         </strong>
         – Fever should be treated with
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         . (See
         <a class="local">
          'Symptom management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Newborns
         </strong>
         – Asymptomatic newborns (born in the hospital with infection control precautions) should be considered exposed, not infected. These newborns may receive care in the nursery using standard precautions and should be observed for signs of infection; routine use of antiviral prophylaxis is
         <strong>
          not
         </strong>
         recommended. (See
         <a class="local">
          'Newborns'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Household contacts and infant caregivers
         </strong>
         – All eligible household members and infant caretakers should be vaccinated against influenza virus. Issues related to antiviral prophylaxis for household members and infant caretakers who have close contact with an individual with influenza are discussed separately. (See
         <a class="local">
          'Household contacts and infant caregivers'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/7017.html" rel="external">
          "Seasonal influenza in adults: Role of antiviral prophylaxis for prevention", section on 'Postexposure antiviral prophylaxis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention
         </strong>
         (See
         <a class="local">
          'Vaccination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We recommend influenza virus vaccination for all patients who are pregnant or will be pregnant or postpartum during influenza season (
         <a class="grade" href="https:///uptodate/show/grade_1" rel="external">
          Grade 1A
         </a>
         ), regardless of pregnancy trimester. Issues related to timing are discussed above. Influenza vaccination during pregnancy provides maternal protection and also may reduce risk for influenza illness among infants during their first six months of life (when they are too young to receive the influenza vaccine).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Such patients should be immunized with any licensed
         <a class="drug drug_general" data-topicid="9055" href="/z/d/drug information/9055.html" rel="external">
          inactivated influenza vaccine
         </a>
         (IIV) or recombinant influenza vaccine; they should
         <strong>
          not
         </strong>
         be immunized with a live-attenuated influenza vaccine (LAIV). No increased risk of adverse pregnancy or fetal outcomes have been observed among pregnant patients who have received influenza vaccination.
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season. MMWR Recomm Rep 2023;72(No. RR-2):1–25.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uyeki TM. Influenza. Ann Intern Med 2021; 174:ITC161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis 2019; 68:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ACOG Committee Opinion No. 753: Assessment and Treatment of Pregnant Women With Suspected or Confirmed Influenza. Obstet Gynecol 2018; 132:e169. Reaffirmed 2021.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011; 205:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meijer WJ, van Noortwijk AG, Bruinse HW, Wensing AM. Influenza virus infection in pregnancy: a review. Acta Obstet Gynecol Scand 2015; 94:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prasad N, Huang QS, Wood T, et al. Influenza-Associated Outcomes Among Pregnant, Postpartum, and Nonpregnant Women of Reproductive Age. J Infect Dis 2019; 219:1893.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013; 347:f5061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           FREEMAN DW, BARNO A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959; 78:1172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hardy JM, Azarowicz EN, Mannini A, et al. The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958. Am J Public Health Nations Health 1961; 51:1182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris JW. Influenza occurring in pregnant women. JAMA 1919; 72:978.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodds L, McNeil SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007; 176:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wen T, Arditi B, Riley LE, et al. Influenza Complicating Delivery Hospitalization and Its Association With Severe Maternal Morbidity in the United States, 2000-2018. Obstet Gynecol 2021; 138:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303:1517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Callaghan WM, Creanga AA, Jamieson DJ. Pregnancy-Related Mortality Resulting From Influenza in the United States During the 2009-2010 Pandemic. Obstet Gynecol 2015; 126:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holstein R, Dawood FS, O'Halloran A, et al. Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019 : A Repeated Cross-Sectional Study. Ann Intern Med 2022; 175:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irving WL, James DK, Stephenson T, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 2000; 107:1282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luteijn JM, Brown MJ, Dolk H. Influenza and congenital anomalies: a systematic review and meta-analysis. Hum Reprod 2014; 29:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 2005; 16:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)--United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep 2011; 60:1193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bloom-Feshbach K, Simonsen L, Viboud C, et al. Natality decline and miscarriages associated with the 1918 influenza pandemic: the Scandinavian and United States experiences. J Infect Dis 2011; 204:1157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McNeil SA, Dodds LA, Fell DB, et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol 2011; 204:S54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mendez-Figueroa H, Raker C, Anderson BL. Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic. Am J Obstet Gynecol 2011; 204:S58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yates L, Pierce M, Stephens S, et al. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess 2010; 14:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Håberg SE, Trogstad L, Gunnes N, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013; 368:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Filho JQ, Junior FS, Lima TBR, et al. Perinatal Outcomes of Asynchronous Influenza Vaccination, Ceará, Brazil, 2013-2018. Emerg Infect Dis 2021; 27:2409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regan AK, Feldman BS, Azziz-Baumgartner E, et al. An international cohort study of birth outcomes associated with hospitalized acute respiratory infection during pregnancy. J Infect 2020; 81:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newsome K, Alverson CJ, Williams J, et al. Outcomes of infants born to women with influenza A(H1N1)pdm09. Birth Defects Res 2019; 111:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen C, Desai S, Bredfeldt C, et al. A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis 2012; 206:1260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chow EJ, Beigi RH, Riley LE, Uyeki TM. Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy. Open Forum Infect Dis 2021; 8:ofab138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lian J, Adilijiang M, Chang C, et al. Neonatal outcomes after neuraminidase inhibitor use during pregnancy: A meta-analysis of cohort studies. Br J Clin Pharmacol 2022; 88:911.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Bennekom CM, Kerr SM, Mitchell AA. Oseltamivir exposure in pregnancy and the risk of specific birth defects. Birth Defects Res 2019; 111:1479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wentges-van Holthe N, van Eijkeren M, van der Laan JW. Oseltamivir and breastfeeding. Int J Infect Dis 2008; 12:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greer LG, Leff RD, Rogers VL, et al. Pharmacokinetics of oseltamivir according to trimester of pregnancy. Am J Obstet Gynecol 2011; 204:S89.
          </a>
         </li>
         <li class="breakAll">
          Oseltamivir http://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm (Accessed on December 14, 2015).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen SA, Kissin DM, Yeung LF, et al. Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns. Am J Obstet Gynecol 2011; 204:S13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards MJ. Review: Hyperthermia and fever during pregnancy. Birth Defects Res A Clin Mol Teratol 2006; 76:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrova A, Demissie K, Rhoads GG, et al. Association of maternal fever during labor with neonatal and infant morbidity and mortality. Obstet Gynecol 2001; 98:20.
          </a>
         </li>
         <li class="breakAll">
          Interim guidance: Considerations regarding 2009 H1N1 influenza in intrapartum and postpartum hospital settings. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/h1n1flu/guidance/obstetric.htm (Accessed on April 11, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy. Obstet Gynecol 2018; 131:e109. Reaffirmed 2021.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zerbo O, Ray GT, Zhang L, et al. Individual and Neighborhood Factors Associated With Failure to Vaccinate Against Influenza During Pregnancy. Am J Epidemiol 2020; 189:1379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Razzaghi H, Kahn KE, Calhoun K, et al. Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women - United States, April 2023. MMWR Morb Mortal Wkly Rep 2023; 72:1065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mena G, Casas I, Casañ C, et al. Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season. PLoS One 2021; 16:e0260397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindley MC, Kahn KE, Bardenheier BH, et al. Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants — United States. MMWR Morb Mortal Wkly Rep 2019; 68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McHugh L, O'Grady KF, Nolan T, et al. National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012-2015. Aust N Z J Public Health 2021; 45:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jamieson DJ, Kissin DM, Bridges CB, Rasmussen SA. Benefits of influenza vaccination during pregnancy for pregnant women. Am J Obstet Gynecol 2012; 207:S17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlaudecker EP, McNeal MM, Dodd CN, et al. Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis 2012; 206:1670.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Demicheli V, Jefferson T, Al-Ansary LA, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2014; :CD001269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinhoff MC, Katz J, Englund JA, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis 2017; 17:981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson MG, Li DK, Shifflett P, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis 2014; 58:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson MG, Kwong JC, Regan AK, et al. Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016. Clin Infect Dis 2019; 68:1444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratton KN, Wardle MT, Orenstein WA, Omer SB. Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis 2015; 60:e11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinhoff MC, Omer SB, Roy E, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012; 184:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Omer SB, Goodman D, Steinhoff MC, et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011; 8:e1000441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fell DB, Sprague AE, Liu N, et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 2012; 102:e33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Legge A, Dodds L, MacDonald NE, et al. Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ 2014; 186:E157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olsen SJ, Frank-Stromborg M. Cancer prevention and screening activities reported by African-American nurses. Oncol Nurs Forum 1994; 21:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014; 371:918.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eick AA, Uyeki TM, Klimov A, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011; 165:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011; 204:S141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benowitz I, Esposito DB, Gracey KD, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010; 51:1355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shakib JH, Korgenski K, Presson AP, et al. Influenza in Infants Born to Women Vaccinated During Pregnancy. Pediatrics 2016; 137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nunes MC, Cutland CL, Jones S, et al. Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial. JAMA Pediatr 2016; 170:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tapia MD, Sow SO, Tamboura B, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis 2016; 16:1026.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohfuji S, Deguchi M, Tachibana D, et al. Protective Effect of Maternal Influenza Vaccination on Influenza in Their Infants: A Prospective Cohort Study. J Infect Dis 2018; 217:878.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazagatos C, Godoy P, Muñoz Almagro C, et al. Effectiveness of influenza vaccination during pregnancy to prevent severe infection in children under 6 months of age, Spain, 2017-2019. Vaccine 2020; 38:8405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jarvis JR, Dorey RB, Warricker FDM, et al. The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis. Vaccine 2020; 38:1601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wutzler P, Schmidt-Ott R, Hoyer H, Sauerbrei A. Prevalence of influenza A and B antibodies in pregnant women and their offspring. J Clin Virol 2009; 46:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlaudecker EP, Steinhoff MC, Omer SB, et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLoS One 2013; 8:e70867.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groothuis JR, Levin MJ, Rabalais GP, et al. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991; 87:823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halasa NB, Gerber MA, Chen Q, et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 2008; 197:1448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nunes MC, Cutland CL, Jones S, et al. Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial. Clin Infect Dis 2017; 65:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regan AK, de Klerk N, Moore HC, et al. Effect of Maternal Influenza Vaccination on Hospitalization for Respiratory Infections in Newborns: A Retrospective Cohort Study. Pediatr Infect Dis J 2016; 35:1097.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fell DB, Platt RW, Lanes A, et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 2015; 122:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mehrabadi A, Dodds L, MacDonald NE, et al. Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes. JAMA 2021; 325:2285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tamma PD, Ault KA, del Rio C, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009; 201:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pasternak B, Svanström H, Mølgaard-Nielsen D, et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012; 308:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irving SA, Kieke BA, Donahue JG, et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol 2013; 121:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nordin JD, Kharbanda EO, Benitez GV, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol 2013; 121:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kharbanda EO, Vazquez-Benitez G, Lipkind H, et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol 2013; 122:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nordin JD, Kharbanda EO, Vazquez Benitez G, et al. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 2014; 164:1051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polyzos KA, Konstantelias AA, Pitsa CE, Falagas ME. Maternal Influenza Vaccination and Risk for Congenital Malformations: A Systematic Review and Meta-analysis. Obstet Gynecol 2015; 126:1075.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regan AK, Moore HC, de Klerk N, et al. Seasonal Trivalent Influenza Vaccination During Pregnancy and the Incidence of Stillbirth: Population-Based Retrospective Cohort Study. Clin Infect Dis 2016; 62:1221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ludvigsson JF, Ström P, Lundholm C, et al. Risk for Congenital Malformation With H1N1 Influenza Vaccine: A Cohort Study With Sibling Analysis. Ann Intern Med 2016; 165:848.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zerbo O, Qian Y, Yoshida C, et al. Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder. JAMA Pediatr 2017; 171:e163609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hviid A, Svanström H, Mølgaard-Nielsen D, Lambach P. Association Between Pandemic Influenza A(H1N1) Vaccination in Pregnancy and Early Childhood Morbidity in Offspring. JAMA Pediatr 2017; 171:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walsh LK, Donelle J, Dodds L, et al. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. BMJ 2019; 366:l4151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foo DYP, Sarna M, Pereira G, et al. Early Childhood Health Outcomes Following In Utero Exposure to Influenza Vaccines: A Systematic Review. Pediatrics 2020; 146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ludvigsson JF, Winell H, Sandin S, et al. Maternal Influenza A(H1N1) Immunization During Pregnancy and Risk for Autism Spectrum Disorder in Offspring : A Cohort Study. Ann Intern Med 2020; 173:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panagiotakopoulos L, McCarthy NL, Tepper NK, et al. Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink. Obstet Gynecol 2020; 136:1086.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romano CJ, Hall C, Khodr ZG, et al. History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects. Vaccine 2021; 39:6553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regan AK, Wesselink AK, Wang TR, et al. Risk of Miscarriage in Relation to Seasonal Influenza Vaccination Before or During Pregnancy. Obstet Gynecol 2023; 142:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jamieson DJ, Rasmussen SA. The safety of adjuvants in influenza vaccines during pregnancy: what do we know and why do we need them? Am J Obstet Gynecol 2012; 207:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heikkinen T, Young J, van Beek E, et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012; 207:177.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Källén B, Olausson PO. Vaccination against H1N1 influenza with Pandemrix(®) during pregnancy and delivery outcome: a Swedish register study. BJOG 2012; 119:1583.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15870 Version 109.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season. MMWR Recomm Rep 2023;72(No. RR-2):1–25.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34748378" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Influenza.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30566567" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30247362" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : ACOG Committee Opinion No. 753: Assessment and Treatment of Pregnant Women With Suspected or Confirmed Influenza.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21345415" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26012384" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Influenza virus infection in pregnancy: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30690449" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Influenza-Associated Outcomes Among Pregnant, Postpartum, and Nonpregnant Women of Reproductive Age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23974637" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13824729" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Deaths from Asian influenza associated with pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13711529" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Influenza occurring in pregnant women
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17296958" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34237767" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Influenza Complicating Delivery Hospitalization and Its Association With Severe Maternal Morbidity in the United States, 2000-2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20407061" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19643469" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : H1N1 2009 influenza virus infection during pregnancy in the USA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26244541" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Pregnancy-Related Mortality Resulting From Influenza in the United States During the 2009-2010 Pandemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34958603" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019 : A Repeated Cross-Sectional Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11028582" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24365800" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Influenza and congenital anomalies: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15703536" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21900872" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)--United States, April 2009-August 2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21917887" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Natality decline and miscarriages associated with the 1918 influenza pandemic: the Scandinavian and United States experiences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21640231" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Effect of respiratory hospitalization during pregnancy on infant outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21457913" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20630123" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23323868" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Risk of fetal death after pandemic influenza virus infection or vaccination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34424181" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Perinatal Outcomes of Asynchronous Influenza Vaccination, Ceará, Brazil, 2013-2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32325131" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : An international cohort study of birth outcomes associated with hospitalized acute respiratory infection during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30623611" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Outcomes of infants born to women with influenza A(H1N1)pdm09.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22859826" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34189160" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21248682" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34378216" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Neonatal outcomes after neuraminidase inhibitor use during pregnancy: A meta-analysis of cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31397115" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Oseltamivir exposure in pregnancy and the risk of specific birth defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18243025" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Oseltamivir and breastfeeding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21492824" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Pharmacokinetics of oseltamivir according to trimester of pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21492824" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Pharmacokinetics of oseltamivir according to trimester of pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21333967" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16933304" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Review: Hyperthermia and fever during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11430951" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Association of maternal fever during labor with neonatal and infant morbidity and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11430951" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Association of maternal fever during labor with neonatal and infant morbidity and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29578985" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32735018" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Individual and Neighborhood Factors Associated With Failure to Vaccinate Against Influenza During Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37768879" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women - United States, April 2023.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34855801" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants—United States
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34411398" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012-2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22920053" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Benefits of influenza vaccination during pregnancy for pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22984116" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Pregnancy modifies the antibody response to trivalent influenza immunization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24623315" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Vaccines for preventing influenza in healthy adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28522338" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18799552" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Effectiveness of maternal influenza immunization in mothers and infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24280090" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30307490" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25409473" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22353593" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21655318" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22515877" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24396098" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8052545" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Cancer prevention and screening activities reported by African-American nurses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25184864" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Influenza vaccination of pregnant women and protection of their infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20921345" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Maternal influenza vaccination and effect on influenza virus infection in young infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21492825" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Impact of maternal immunization on influenza hospitalizations in infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21058908" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27244843" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Influenza in Infants Born to Women Vaccinated During Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27380464" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27261067" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29216373" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Protective Effect of Maternal Influenza Vaccination on Influenza in Their Infants: A Prospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32741669" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Effectiveness of influenza vaccination during pregnancy to prevent severe infection in children under 6 months of age, Spain, 2017-2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31932138" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19643662" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Prevalence of influenza A and B antibodies in pregnant women and their offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23967126" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2034485" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18444800" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Safety and immunogenicity of trivalent inactivated influenza vaccine in infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28575286" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27314823" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Effect of Maternal Influenza Vaccination on Hospitalization for Respiratory Infections in Newborns: A Retrospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25040307" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Fetal death and preterm birth associated with maternal influenza vaccination: systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34100870" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19850275" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Safety of influenza vaccination during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22782418" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23262941" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Trivalent inactivated influenza vaccine and spontaneous abortion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23635613" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Maternal safety of trivalent inactivated influenza vaccine in pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23921876" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24582484" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Maternal influenza vaccine and risks for preterm or small for gestational age birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26444106" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Maternal Influenza Vaccination and Risk for Congenital Malformations: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27033634" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Seasonal Trivalent Influenza Vaccination During Pregnancy and the Incidence of Stillbirth: Population-Based Retrospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27654505" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Risk for Congenital Malformation With H1N1 Influenza Vaccine: A Cohort Study With Sibling Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27893896" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27893898" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Association Between Pandemic Influenza A(H1N1) Vaccination in Pregnancy and Early Childhood Morbidity in Offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31292120" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32719088" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Early Childhood Health Outcomes Following In Utero Exposure to Influenza Vaccines: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32866418" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Maternal Influenza A(H1N1) Immunization During Pregnancy and Risk for Autism Spectrum Disorder in Offspring : A Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33156197" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34598819" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37535959" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Risk of Miscarriage in Relation to Seasonal Influenza Vaccination Before or During Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22939714" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : The safety of adjuvants in influenza vaccines during pregnancy: what do we know and why do we need them?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22939717" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22901103" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Vaccination against H1N1 influenza with Pandemrix(®) during pregnancy and delivery outcome: a Swedish register study.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
